FDA slaps highest risk label on St. Jude Medical's Amplatzer TorqVue FX recall

February 12, 2013 by MassDevice staff

St. Jude Medical recalls its Amplatzer TorqVue FX delivery system over concerns about fractures in the core wire.

Corrected February 13, 2013, at 12:00 p.m. to clarify that the recalled component is part of the Amplatzer Atrial Septal Occluder.

St. Jude Medical logo

The FDA issued the highest-risk label on St. Jude Medical's (NYSE:STJ) recall of its Amplatzer TorqVue FX delivery system.

St. Jude recalled a component of its Amplatzer Occluder over concerns that part of the delivery system may fracture, potentially causing adverse consequences or even death, according to the FDA report.

The Amplatzer device was designed to treat a hole in the heart that, if left unclosed, may allow blood clots to travel from 1 side of the hart to the other and then to the brain, causing a stroke.

Sign up to get our free newsletters delivered right to your inbox.

"The company has identified that in a small number of cases, the core wire could potentially fracture when exposed to a combination of certain cardiac anatomies and implant practices," St. Jude spokeswoman Amy Jo Meyer told MassDevice.com. "To date, no serious injuries have occurred as a result of this issue and if the device has already been used successfully, there is no cause for concern or additional action."

St. Jude began notifying its customers via an "Urgent Medical Device Recall Notice" sent to customers last month, according to the FDA notice.